Llwytho...
Posttranslational Modifications of PD-L1 and Their Applications in Cancer Therapy
Posttranslational modifications (PTMs) of PD-L1 have emerged as important regulatory mechanisms that modulate immunosuppression in cancer patients. In exposure to inflammatory cytokines, cancer cells and antigen-presenting cells, such as macrophages and dendritic cells express PD-L1 to inhibit the a...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cancer Res |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6242346/ https://ncbi.nlm.nih.gov/pubmed/30442814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-18-1892 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|